🕵️ DARE Bioscience, Inc. ($DARE)
SEC insider & ownership activity, last 12 months · CIK 1401914 · every row links its SEC filing
Insiders were quiet over the last 12 months – no open-market buys or sells. One red-flag 8-K in the window: Delisting notice (3.01), Jul 13, 2026.
Insider flow
0 buyers, $0 (0 lots) · 0 sellers, $0 (0 lots)
No open-market insider transactions in the last 12 months.
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| L1 Capital Global Opportunities Master Fund, Ltd. | 10.0% | 13G | Aug 24, 2026 | filing ↗ | |
| LIND Global Fund III LP | 5.7% | 13G | Aug 28, 2026 | filing ↗ | |
| LIND Global Partners III LLC | 5.7% | 13G | Aug 28, 2026 | filing ↗ | |
| Easton Jeff | 5.7% | 13G | Aug 28, 2026 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Charter/bylaw changes (5.03) | Sep 10, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Sep 9, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Sep 9, 2026 | filing ↗ |
| Material agreement (1.01) | Aug 14, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Aug 14, 2026 | filing ↗ |
| Other events (8.01) | Aug 14, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 14, 2026 | filing ↗ |
| Earnings (2.02) | Aug 13, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 13, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jul 24, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 24, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jul 13, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 13, 2026 | filing ↗ |
| Delisting notice (3.01) | Jul 13, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jun 22, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 22, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jun 11, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jun 11, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 11, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | May 14, 2026 | filing ↗ |
| Earnings (2.02) | May 14, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | May 1, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Apr 22, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 22, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Apr 17, 2026 | filing ↗ |
| Officer/director changes (5.02) | Apr 16, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Apr 10, 2026 | filing ↗ |
| Earnings (2.02) | Mar 26, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 26, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Mar 16, 2026 | filing ↗ |